[sixty one] shown that the CRISPR/Cas9 process could specifically target and cleave conserved areas while in the HBV genome, leading to robust suppression of viral gene expression and replication each in vitro and in vivoMoreover, a combination of antiviral medicine using an immune-modulator could enhance the elimination of cccDNA and supply a defi